Graham Capital Management L.P. Invests $170,000 in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Graham Capital Management L.P. purchased a new position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) during the 4th quarter, HoldingsChannel reports. The fund purchased 10,086 shares of the biotechnology company’s stock, valued at approximately $170,000. Other institutional investors have also recently made changes to their positions in the company. China Universal Asset Management Co. […]
